|
|
See Category: Neoplasms
See Header: Squamous cell carcinoma of skin of lower limb, including hip
ICD-10 (CM) Code and Descriptor
|
C44.729 |
Squamous cell carcinoma of skin of left lower limb, including hip
|
C44729 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.80%
|
24.09%
|
9.96%
|
5.36%
|
3.33%
|
1.86%
|
1.58%
|
0.87%
|
0.55%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.729*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4,606
|
6,037
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,775
|
2,779
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
1,779
|
1,779
|
|
17313
|
MOHS 1 STAGE T/A/L |
1,370
|
1,425
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
754
|
754
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
718
|
718
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
671
|
18,232
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
597
|
604
|
|
J3010
|
FENTANYL CITRATE INJECTION |
591
|
794
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
538
|
1,988
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
504
|
697
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
468
|
468
|
|
J2405
|
ONDANSETRON HCL INJECTION |
460
|
1,888
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
435
|
436
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
430
|
433
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
403
|
404
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
391
|
391
|
|
17000
|
DESTRUCT PREMALG LESION |
369
|
369
|
|
17314
|
MOHS ADDL STAGE T/A/L |
362
|
393
|
|
77336
|
RADIATION PHYSICS CONSULT |
351
|
351
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.729 related to the following DRG Codes:
606-607
|
